SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-035092
Filing Date
2023-12-21
Accepted
2023-12-21 16:05:27
Documents
13
Period of Report
2023-12-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K crvo20231221_8k.htm   iXBRL 8-K 30909
  Complete submission text file 0001437749-23-035092.txt   162815

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA crvo-20231221.xsd EX-101.SCH 3410
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crvo-20231221_def.xml EX-101.DEF 11425
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE crvo-20231221_lab.xml EX-101.LAB 15311
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crvo-20231221_pre.xml EX-101.PRE 11585
7 EXTRACTED XBRL INSTANCE DOCUMENT crvo20231221_8k_htm.xml XML 2543
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 231505312
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)